Cardlytics Inc

CDLX

Market Cap$575.19M

Close$

Compare Cardlytics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Cardlytics Inc	-4.3	0%	-100%	1.9	1.9
Market Avg	59	1.3%	30%	-	1
Consumer Discretionary Avg	26	0.69%	72%	3.1	1.2

$17.00

Target Price by Analysts

46.7% upsideCardlytics Target Price Details

$20.92

Current Fair Value

80.5% upside

Undervalued by 80.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$575.19 Million
Enterprise Value	$740.94 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-3.69
Beta	2.93
Outstanding Shares	48,173,734
Avg 30 Day Volume	2,409,430

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-4.27
PEG	5.82
Price to Sales	1.93
Price to Book Ratio	5.8
Enterprise Value to Revenue	2.4
Enterprise Value to EBIT	-11.64
Enterprise Value to Net Income	-6
Total Debt to Enterprise	0.35
Debt to Equity	1.91

Revenue Sources

No data

ESG Score

No data

About Cardlytics Inc

CEO: Lynne Laube